Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias (DCP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by Emory University
Sponsor:
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Office of Rare Diseases (ORD)
Allergan
Dystonia Study Group
Information provided by (Responsible Party):
Hyder A. Jinnah, MD, PhD, Emory University
ClinicalTrials.gov Identifier:
NCT01373424
First received: June 2, 2011
Last updated: May 18, 2016
Last verified: May 2016

June 2, 2011
May 18, 2016
January 2011
June 2017   (final data collection date for primary outcome measure)
Observational [ Time Frame: 7 years ] [ Designated as safety issue: No ]
There is no primary outcome measure as this is an observational study.
Not Provided
Complete list of historical versions of study NCT01373424 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
Natural History and Biospecimen Repository for Dystonia; Comprehensive Rating Tools for Cervical Dystonia; Validity & Reliability of Diagnostic Methods & Measures of Spasmodic Dysphonia
Dystonia is a disorder characterized by excessive involuntary contraction of muscles with repetitive and patterned movements. The isolated dystonias are the most common type of dystonia and include Limb dystonias (like writer's cramp), Cervical dystonia (spasmodic torticollis), Laryngeal dystonias (like spasmodic dysphonia), and Craniofacial dystonias (like blepharospasm). The purpose of this study is to create resources to help learn more about the isolated dystonias, myoclonus dystonia, and dopa-responsive dystonia and to develop and validate various dystonia rating scales.

This collaborative, international effort has one primary goal. This is to create a biospecimen repository and associated clinical database to be used as a resource for dystonia and related disease research. Across sites, the investigators hope to enroll at least 5,000 adult patients.

Subjects of this study will be asked to complete a neurological exam which will be video recorded, complete some questionnaires, and donate a blood sample. A study visit will take between 45 minutes and 1 hour. All subjects will be asked to return every 1, 2, 3, or 4 years for a one hour follow-up visit. People may participate in this study without agreeing to participate in the follow-up visits.

Observational
Not Provided
Not Provided
Retention:   Samples With DNA
Description:
Whole blood, DNA, white blood cells, cell lines
Non-Probability Sample
People with dystonia are eligible to participate as long as they are above age 18 and fit the eligibility criteria. The coordinator at the site you contact can tell you more about this.
Dystonia
Not Provided
  • Cervical dystonia
    People diagnosed with cervical dystonia
  • Laryngeal dystonia
    People diagnosed with laryngeal dystonia
  • Other voice disorders
    People diagnosed with a voice disorder other than laryngeal dystonia - enrollment for this group is complete
  • Craniofacial dystonia
    People diagnosed with craniofacial dystonia (including blepharospasm, meige syndrome, and oromandibular dystonia)
  • Limb dystonia
    People diagnosed with limb dystonia
  • All other isolated dystonias
    People diagnosed with any isolated dystonia not listed in descriptions of other cohorts
  • Myoclonus dystonia
    People diagnosed with myoclonus dystonia
  • Dopa-responsive dystonia
    People diagnosed with dopa-responsive dystonia
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
5000
Not Provided
June 2017   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosed with isolated dystonia or myoclonus dystonia or dopa-responsive dystonia
  • To be included in laryngeal dystonia group, nasolaryngoscopy (voice box exam) must have been completed to confirm diagnosis (this voice box exam is not part of the study)

Exclusion Criteria:

  • Any evidence of a secondary cause for dystonia (other than myoclonus dystonia or dopa-responsive dystonia)
  • Less than 2 months since last botulinum toxin injection
  • Inability to provide informed consent
  • Significant medical or neurological conditions that preclude completing the neurological exam
  • Significant physical or other condition that would confound diagnosis or evaluation, other than dystonia or tremor
Both
18 Years and older   (Adult, Senior)
No
Contact: Ami R Rosen, MS, CGC 404-727-3381 arosen3@emory.edu
United States,   Australia,   Canada,   France,   Germany,   Italy,   United Kingdom
 
NCT01373424
IRB00046266, U54TR001456, RDCRN#6301, U54NS065701
No
Yes
Data is available to researchers with appropriate ethics board approvals. Researchers may contact the Dystonia Coalition PI or coordinator at Emory University or the RDCRN Data Management and Coordination Center for more information.
Hyder A. Jinnah, MD, PhD, Emory University
Hyder A. Jinnah, MD, PhD
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • Office of Rare Diseases (ORD)
  • Allergan
  • Dystonia Study Group
Principal Investigator: H. A. Jinnah, MD, PhD Emory University
Emory University
May 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP